Request Free Sample
×
UK Asthma Inhaler Device Market
ID: MRFR/HC/54548-HCR
200 Pages
June 2025
UK Asthma Inhaler Device Market Research Report: By Type (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), By Mode of Operation (Manually Operated Inhaler Devices, Digitally-Operated Inhaler Devices) andBy End User (Hospitals & Clinics, Homecare)- Forecast to 2035
Industry Developments
In the UK Asthma Inhaler Device Market, recent developments include a notable push towards improved technology and more environmentally friendly inhalers, with companies like GlaxoSmithKline and AstraZeneca leading innovations. Current affairs highlight ongoing discussions around the accessibility of inhaler devices, emphasizing initiatives to ensure affordability for all segments of the population. In terms of mergers and acquisitions, recent months have seen AbbVie acquiring Allergan bolstering its position in respiratory treatments, while Merck & Co has expanded its portfolio through strategic collaborations with various biotech firms. The market has been positively impacted by robust growth trends wherein companies like Boehringer Ingelheim and Novartis have reported increased sales, attributed to a rise in asthma prevalence and an emphasis on initiative-taking asthma management strategies. Furthermore, major events in the sector, such as regulatory approvals in early 2023 for new inhaler devices demonstrating improved efficacy, underline the dynamic nature of this market. Over the past two to three years, significant investments have flowed into Research and Development in the UK, aimed at fostering innovation and ensuring that patient needs are met effectively and promptly.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 78.4(USD Million) |
| MARKET SIZE 2024 | 86.24(USD Million) |
| MARKET SIZE 2035 | 196.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.749% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | AbbVie, Valeant Pharmaceuticals, GlaxoSmithKline, Roche, Boehringer Ingelheim, Chiesi Farmaceutici, Mylan, Novartis, Hikma Pharmaceuticals, Sandoz, Teva Pharmaceutical Industries, Sun Pharmaceutical Industries, AstraZeneca, Merck & Co, Cipla |
| SEGMENTS COVERED | Type, Mode of Operation, End User |
| KEY MARKET OPPORTUNITIES | Telehealth integration solutions, Smart inhaler technology, Personalized medication delivery systems, Eco-friendly inhaler options, Increased awareness and education programs |
| KEY MARKET DYNAMICS | rising asthma prevalence, technological advancements, regulatory changes, increasing consumer awareness, healthcare cost pressures |
| COUNTRIES COVERED | UK |
FAQs
What is the expected market size of the UK Asthma Inhaler Device Market in 2024?
The UK Asthma Inhaler Device Market is expected to be valued at 86.24 million USD in 2024.
How much is the UK Asthma Inhaler Device Market projected to grow by 2035?
By 2035, the UK Asthma Inhaler Device Market is projected to grow to a value of 196.0 million USD.
What is the expected compound annual growth rate (CAGR) for the UK Asthma Inhaler Device Market from 2025 to 2035?
The CAGR for the UK Asthma Inhaler Device Market is expected to be 7.749% from 2025 to 2035.
What is the market value of Metered Dose Inhalers in 2024 and 2035?
The market value of Metered Dose Inhalers is projected to be 40.0 million USD in 2024 and 90.0 million USD in 2035.
How does the market size for Dry Powder Inhalers compare between 2024 and 2035?
The market for Dry Powder Inhalers is expected to grow from 30.0 million USD in 2024 to 66.0 million USD in 2035.
What is the anticipated market size for Soft Mist Inhalers by 2035?
By 2035, the anticipated market size for Soft Mist Inhalers is expected to reach 40.0 million USD.
Who are the major players in the UK Asthma Inhaler Device Market?
Major players in the UK Asthma Inhaler Device Market include AbbVie, GlaxoSmithKline, Roche, and AstraZeneca among others.
What growth opportunities exist in the UK Asthma Inhaler Device Market?
Opportunities in the market are driven by technological advancements and increasing awareness of asthma management.
What challenges does the UK Asthma Inhaler Device Market face?
Challenges in the market include regulatory constraints and competition among established players.
How significant are the trends affecting the UK Asthma Inhaler Device Market?
Trends such as increased personalization of treatment and patient adherence strategies are significantly impacting the market.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense
Leave a Comment